De Novo Variants in MAPK8IP3 Cause Intellectual Disability with Variable Brain Anomalies.
Adaptor Proteins, Signal Transducing
/ chemistry
Adolescent
Animals
Brain
/ abnormalities
CRISPR-Cas Systems
Caenorhabditis elegans
/ genetics
Child
Child, Preschool
Computer Simulation
Female
Humans
Intellectual Disability
/ diagnostic imaging
Locomotion
Lysosomes
/ metabolism
Male
Models, Molecular
Mutation
Nerve Tissue Proteins
/ chemistry
Exome Sequencing
Young Adult
MAPK8IP3
brain anomalies
de novo
developmental delay
intellectual disability
neurodevelopmental disorder
polymicrogyria
Journal
American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475
Informations de publication
Date de publication:
07 02 2019
07 02 2019
Historique:
received:
02
11
2018
accepted:
11
12
2018
pubmed:
8
1
2019
medline:
20
11
2019
entrez:
8
1
2019
Statut:
ppublish
Résumé
Using exome sequencing, we have identified de novo variants in MAPK8IP3 in 13 unrelated individuals presenting with an overlapping phenotype of mild to severe intellectual disability. The de novo variants comprise six missense variants, three of which are recurrent, and three truncating variants. Brain anomalies such as perisylvian polymicrogyria, cerebral or cerebellar atrophy, and hypoplasia of the corpus callosum were consistent among individuals harboring recurrent de novo missense variants. MAPK8IP3 has been shown to be involved in the retrograde axonal-transport machinery, but many of its specific functions are yet to be elucidated. Using the CRISPR-Cas9 system to target six conserved amino acid positions in Caenorhabditis elegans, we found that two of the six investigated human alterations led to a significantly elevated density of axonal lysosomes, and five variants were associated with adverse locomotion. Reverse-engineering normalized the observed adverse effects back to wild-type levels. Combining genetic, phenotypic, and functional findings, as well as the significant enrichment of de novo variants in MAPK8IP3 within our total cohort of 27,232 individuals who underwent exome sequencing, we implicate de novo variants in MAPK8IP3 as a cause of a neurodevelopmental disorder with intellectual disability and variable brain anomalies.
Identifiants
pubmed: 30612693
pii: S0002-9297(18)30459-2
doi: 10.1016/j.ajhg.2018.12.008
pmc: PMC6369540
pii:
doi:
Substances chimiques
Adaptor Proteins, Signal Transducing
0
MAPK8IP3 protein, human
0
Nerve Tissue Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
203-212Informations de copyright
Copyright © 2018 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Références
Electrophoresis. 1997 Dec;18(15):2714-23
pubmed: 9504803
J Biol Chem. 2015 Jun 19;290(25):15512-25
pubmed: 25944905
J Neuropathol Exp Neurol. 2011 Jun;70(6):438-43
pubmed: 21572338
Biochem Biophys Res Commun. 2017 Apr 15;485(4):790-795
pubmed: 28259553
Nat Rev Genet. 2016 Jan;17(1):9-18
pubmed: 26503795
J Biol Chem. 2013 May 17;288(20):14531-43
pubmed: 23576431
J Med Genet. 2017 Apr;54(4):260-268
pubmed: 27884935
Annu Rev Genet. 2013;47:139-65
pubmed: 24274751
Neurobiol Dis. 2010 May;38(2):154-66
pubmed: 19245832
Protein Cell. 2011 Mar;2(3):202-14
pubmed: 21468892
Nat Genet. 2013 Jun;45(6):639-47
pubmed: 23603762
Genet Med. 2018 Nov;20(11):1354-1364
pubmed: 29671837
Genetics. 2013 May;194(1):143-61
pubmed: 23633144
Nat Genet. 2010 Dec;42(12):1109-12
pubmed: 21076407
PLoS Genet. 2013;9(2):e1003303
pubmed: 23468645
Neuroscientist. 2017 Jun;23(3):232-250
pubmed: 27154488
Nat Genet. 2014 Sep;46(9):944-50
pubmed: 25086666
Trends Biochem Sci. 1995 Sep;20(9):374
pubmed: 7482707
Am J Hum Genet. 2017 Nov 2;101(5):664-685
pubmed: 29100083
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12593-8
pubmed: 8901627
Nat Rev Neurosci. 2013 Mar;14(3):161-76
pubmed: 23361386
Structure. 2018 Nov 6;26(11):1486-1498.e6
pubmed: 30197037
Res Dev Disabil. 2011 Mar-Apr;32(2):419-36
pubmed: 21236634
Trends Biochem Sci. 2010 Oct;35(10):565-74
pubmed: 20451393
Nature. 2017 Feb 23;542(7642):433-438
pubmed: 28135719
Cold Spring Harb Perspect Med. 2015 May 01;5(5):a022392
pubmed: 25934463
Trends Neurosci. 2013 Nov;36(11):641-51
pubmed: 24035135
Lancet Neurol. 2013 Apr;12(4):406-14
pubmed: 23518333
Dev Neurobiol. 2009 Feb 1-15;69(2-3):174-90
pubmed: 19105215
J Neurosci. 2011 Jul 20;31(29):10602-14
pubmed: 21775604
Neuromuscul Disord. 2016 Nov;26(11):744-748
pubmed: 27751653
Hum Genet. 2017 Apr;136(4):409-420
pubmed: 28213671
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Brain. 2010 May;133(Pt 5):1415-27
pubmed: 20403963
Hum Genet. 2015 Mar;134(3):305-14
pubmed: 25560765
Nature. 2014 Nov 13;515(7526):216-21
pubmed: 25363768
EMBO J. 2011 Jul 12;30(16):3416-29
pubmed: 21750526
Genetics. 2015 Sep;201(1):117-41
pubmed: 26354976
J Cell Biol. 2017 Oct 2;216(10):3291-3305
pubmed: 28784610
Trends Neurosci. 2010 Jul;33(7):335-44
pubmed: 20434225
Nat Neurosci. 2004 Nov;7(11):1187-9
pubmed: 15494731